These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 13291265)
1. [Danger to patients of therapy with colloidal plasma substitutes]. BUSCH H Ther Ggw; 1955 Sep; 94(9):324-7. PubMed ID: 13291265 [No Abstract] [Full Text] [Related]
2. [Incorporation of physiologically-active substances into a colloidal blood plasma substitute. I. Incorporation of mescaline peptide into polyvinylpyrrolidone]. JATZKEWITZ H Hoppe Seylers Z Physiol Chem; 1954; 297(3-6):149-56. PubMed ID: 13221275 [No Abstract] [Full Text] [Related]
3. A review on the status of the so-called blood plasma substitutes. ATIENZA RY; ZALAMEA RU J Philipp Med Assoc; 1954 Jul; 30(7):346-57. PubMed ID: 13202054 [No Abstract] [Full Text] [Related]
4. The use of polyvinylpyrrolidone as a plasma volume expander in preventing or combating shock. SINGLETON AO Tex Rep Biol Med; 1953; 11(1):138-43. PubMed ID: 13038721 [No Abstract] [Full Text] [Related]
5. Plasma expanders in surgical shock. WEIL PG; BALDRY RE Can Serv Med J; 1954 Dec; 10(5):293-8. PubMed ID: 13209506 [No Abstract] [Full Text] [Related]
6. Plasma expanders in surgical shock. WEIL PG; BALDRY RE Can Hosp; 1955 May; 32(5):47; passim. PubMed ID: 14379067 [No Abstract] [Full Text] [Related]
8. The clinical status of dextran, PVP and gelatin products. PULASKI EJ Int Rec Med Gen Pract Clin; 1952 Aug; 165(8):172-9. PubMed ID: 13010904 [No Abstract] [Full Text] [Related]
9. Plasma expanders in the armed services of the United States. BELL LG U S Armed Forces Med J; 1954 Sep; 5(9):1331-9. PubMed ID: 13196228 [No Abstract] [Full Text] [Related]
14. [Comparative study of the therapeutic action of several solutions of synthetic polymers and the protein hydrolysate]. Chaplygina ZA; Mikhaĭlov VI Patol Fiziol Eksp Ter; 1966; 10(6):73-5. PubMed ID: 5246525 [No Abstract] [Full Text] [Related]
15. A comparison of plasma substitutes (dextran, polyvinylpyrrolidone and oxypolygelatin) with saline therapy in treatment of experimental tourniquet and burn shock in mice. MILLICAN RC; STOHLMAN EF; MOWRY RW Am J Physiol; 1952 Jul; 170(1):173-8. PubMed ID: 12985881 [No Abstract] [Full Text] [Related]
16. [The use of hemagel in hospital practice. Review and clinical report]. Jacobellis P; Vitelli M Minerva Chir; 1966 Jan; 21(1):31-6. PubMed ID: 5910989 [No Abstract] [Full Text] [Related]